Log inSign up

SalioGen Therapeutics

1 follower

‌

SalioGen Therapeutics is advancing the Exact DNA Integration Technology (EDIT) platform, the only genome engineering technology that is mammal-derived, for use in potentially curative non-viral gene therapy.

Industries

Biotechnology, Education

Headquarters

Cambridge, United States

Employees

51-200

Links

Org chart

Jason F. Cole
CEO & Chairman

Jason F. Cole

Collapse
Will Mcgown
Executive Director, Finance & FP&A
Jill Murray
VP, Human Resources
Joseph J. Higgins
President & Chief Scientific Officer
Jeff Kopacz
SVP of Intellectual Property & Contracts
Joe Senn
SVP & Head of R&D
Jill Murray, PHR
Vice President Human Resources
William McGowan
Executive Director, Finance And Fp&a
Subhro Guhathakurta
Executive Director, Platform Development & Genetic Engineering
LauraLee Hughes
Director, Corporate Development & Strategy
Pat Sacco
SVP of Manufacturing, Quality & Operations

Teams

BD
+11

Scientific Advisory and Development

14 members

+4

Scientific Research

7 members

+3

Leadership Team

6 members

Offices

This company has no offices yet

Similar companies

Mission Bio

4 followers

UW-Green Bay

9 followers

Stemline Therapeutics

3 followers

Karius

2 followers

Generation Bio

2 followers

The Washington Center

2 followers

Celldex Therapeutics

2 followers

Civitas Learning

2 followers

Apptegy

2 followers

Adicet Bio

1 follower

Vividion Therapeutics

1 follower

Explore companies